Assessment of the Nature of Dyslipoproteinemias and Correlations of Indicators of General Reactivity and Lipid Metabolism in Patients with Chronic Nonspecific Inflammation of the Reproductive System
DOI:
https://doi.org/10.17721/fujcV11I2P77-94Keywords:
nature of dyslipoproteinemias, correlation relationships, general reactivity of the body, integral leukogram indicators, lipid metabolism, immunopathological mechanisms, atherosclerosisAbstract
Metabolic disorders can occur at all levels of biological organization - from molecular and cellular to the level of the organism as a whole. These changes may result from disruptions in hormonal mechanisms, actions of pathogenic factors, or infections. Primary metabolic disorders are the basis of many diseases, such as diabetes, obesity, and atherosclerosis, while secondary disorders accompany most pathological processes. Disruption of lipid metabolism leads to changes in their functions and the development of pathological processes, such as dyslipoproteinemia, and also contributes to the development of atherosclerosis. Various intracellular infectious agents play a significant role in the development of dyslipoproteinemias and atherosclerosis, for example, chlamydia can alter the lipid metabolism in macrophages under the influence of low-density lipoproteins, leading to the formation of 'foam-like' cells. This, in turn, contributes to the development of atheromatous plaques-a favorable environment for chlamydia, where it can survive for an extended period and trigger immunopathological mechanisms.
References
Jellinger P. American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines. Diabetes Spectrum 2018;31(3):234-245. https://doi.org/10.2337/ds18-0009
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L. Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal 2019;41(44):4255-4255. https://doi.org/10.1093/eurheartj/ehz826
Rhee E, Kim H, Kim J, Lee E, Kim B, Kim E, Song Y, Lim J, Kim H, Choi S, Moon M, Na J, Park K, Oh M, Han S, Noh J, Yi K, Lee S, Hong S, Jeong I. 2018 Guidelines for the management of dyslipidemia in Korea. The Korean Journal of Internal Medicine 2019;34(5):1171-1171. https://doi.org/10.3904/kjim.2019.188.e1
Hasheminasabgorji E, Jha J. Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors. Biomedicines 2021;9(11):1602. https://doi.org/10.3390/biomedicines9111602
Zhang T, Chen J, Tang X, Luo Q, Xu D, Yu B. Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids in Health and Disease 2019;18(1):223. https://doi.org/10.1186/s12944-019-1170-9
Sokolovska I, Maryukhnich N, Zarytska V, Kyrpychenko O, Nechiporenko V, Pozdnyakova O, Gordiyenko N, Tsymbal V. The state of lipid exchange and thrombotic link of hemostasis in patients with chronic non-specific inflammatory diseases of genitals. French-Ukrainian Journal of Chemistry 2019;7(1):34-45. https://doi.org/10.17721/fujcv7i1p34-45
Pang J, Chan D, Watts G. The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia. Current Atherosclerosis Reports 2020;22(11):64. https://doi.org/10.1007/s11883-020-00884-2
Daiber A, Chlopicki S. Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies. Free Radical Biology and Medicine 2020;157:15-37. https://doi.org/10.1016/j.freeradbiomed.2020.02.026
Sokolovskaya I, Prybora N, Valentyna Nechyporenko V, Pozdniakova O, Hordiienko N, Nechyporenko K, Siliavina Y, Mavrin V, Kotuza A, Kliusov O, Kryachok I, Tytorenko I, Zub V, Yanitka L, Hordienko N, Kudinova M, Mamedli Z, Hordiienko L, Kmetyuk Y, Sprynchuk N. Assessment of the State of Platelet Haemostasis and Adhesive - Aggregation Properties of Platelets as a Factor of Increasing the Tendency to Thrombosis in Chronic Inflammation. French-Ukrainian Journal of Chemistry 2022;10(2):22-36. https://doi.org/10.17721/fujcv10i2p22-36
Andrabi S, Bekheirnia M, Robbins‐Furman P, Lewis R, Prior T, Potocki L. SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. American Journal of Medical Genetics Part A 2011;155(5):1165-1169. https://doi.org/10.1002/ajmg.a.33968
Scheuer H, Gwinner W, Hohbach J, Gröne E, Brandes R, Malle E, Olbricht C, Walli A, Gröne H. Oxidant stress in hyperlipidemia-induced renal damage. American Journal of Physiology-Renal Physiology 2000;278(1):F63-F74. https://doi.org/10.1152/ajprenal.2000.278.1.f63
Sokolovskaya I, Kryachok I, Chorna I, Semeniv I, Kotuza A, Hryhorieva N, Plakhotnik O, Zarytska V, Zhuravel V, Kmetyuk Y, Kondratiuk A. Influence of exogenous, physiological and factors of chronic inflammatory process on indicators of disturbances of adaptive processes of the person. French-Ukrainian Journal of Chemistry 2020;8(2):183-202. https://doi.org/10.17721/fujcv8i2p183-202
Sokolovskaya I, Kutsak A, Zarytska V, Nechiporenko V, Gordiyenko N, Siliavina Y, Horash K, Plakhotnik O. Investigation of aspects of the interaction of the indicators of lipid exchange, trombocitarian block of hemostasis, total body reactivity and their influence on the psychosomatic harmonization of the man in chronic inflammatory processes. French-Ukrainian Journal of Chemistry 2019;7(2):120-137. https://doi.org/10.17721/fujcv7i2p120-137
Villadangos J, Young L. Antigen-Presentation Properties of Plasmacytoid Dendritic Cells. Immunity 2008;29(3):352-361. https://doi.org/10.1016/j.immuni.2008.09.002
Sokolovskaya I, Nechiporenko V, Gordiyenko N, Pozdnyakova O, Volkova S, Cymbal V, Makurina G. Lipid peroxidation during chronic inflammation. French-Ukrainian Journal of Chemistry 2018;6(2):38-53. https://doi.org/10.17721/fujcv6i2p38-53
Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45-60.
Ginsberg H. Lipoprotein Physiology and Its Relationship to Atherogenesis. Endocrinology and Metabolism Clinics of North America 1990;19(2):211-228. https://doi.org/10.1016/s0889-8529(18)30322-0
Chait A. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias. Spec Top Endocrinol Metab. 1983;5:1-53.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 French-Ukrainian Journal of Chemistry
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
